ENZON PHARMACEUTICALS INC's ticker is ENZN and the CUSIP is 293904108. A total of 80 filers reported holding ENZON PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $0 | – | 420 | 0.0% | 0.00% | – |
| Q4 2015 | $0 | – | 420 | 0.0% | 0.00% | – |
| Q3 2015 | $0 | -100.0% | 420 | -99.5% | 0.00% | – |
| Q2 2015 | $110,000 | +83.3% | 92,204 | +59.9% | 0.00% | – |
| Q1 2015 | $60,000 | – | 57,669 | +13630.7% | 0.00% | – |
| Q4 2014 | $0 | – | 420 | 0.0% | 0.00% | – |
| Q3 2014 | $0 | -100.0% | 420 | -99.4% | 0.00% | – |
| Q2 2014 | $74,000 | +335.3% | 71,994 | +308.3% | 0.00% | – |
| Q1 2014 | $17,000 | +112.5% | 17,631 | +116.4% | 0.00% | – |
| Q4 2013 | $8,000 | -91.3% | 8,148 | -85.3% | 0.00% | – |
| Q3 2013 | $92,000 | – | 55,436 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALGERT GLOBAL LLC | 124,891 | $85,000 | 0.04% |
| Icahn Capital | 5,904,863 | $4,030,000 | 0.01% |
| SEIZERT CAPITAL PARTNERS, LLC | 414,810 | $283,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 473,708 | $323,000 | 0.01% |
| Anson Funds Management LP | 25,000 | $17,000 | 0.01% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 106,908 | $72,000 | 0.01% |
| Spark Investment Management LLC | 57,500 | $39,000 | 0.01% |
| Renaissance Technologies | 3,501,585 | $2,390,000 | 0.01% |
| Concert Wealth Management Inc. | 45,938 | $30,000 | 0.00% |
| CSS LLC/IL | 96,572 | $66,000 | 0.00% |